Evidence map›Paper›PMID 33705397›Full record

ArticlePloS one2021

Explaining placebo effects in an online survey study: Does 'Pavlov' ring a bell?

Rosanne M Smits, Dieuwke S Veldhuijzen, Tim Olde Hartman, Kaya J Peerdeman, Liesbeth M Van Vliet, Henriët Van Middendorp, Ralph C A Rippe, Nico M Wulffraat, Andrea W M Evers

Abstract read
In one paragraph

Article in PloS one, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Can the Open Label Placebo Rationale Be Optimized?Frontiers in pain research (Lausanne, Switzerland) · 2021
    Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Rosanne M SmitsHealth, Medical and Neuropsychology unit, Leiden University, Leiden, The Netherlands.ORCID 0000-0003-2682-2654
Dieuwke S VeldhuijzenHealth, Medical and Neuropsychology unit, Leiden University, Leiden, The Netherlands.
Tim Olde HartmanDepartment of Primary and Community Care, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.
Kaya J PeerdemanHealth, Medical and Neuropsychology unit, Leiden University, Leiden, The Netherlands.
Liesbeth M Van VlietHealth, Medical and Neuropsychology unit, Leiden University, Leiden, The Netherlands.
Henriët Van MiddendorpHealth, Medical and Neuropsychology unit, Leiden University, Leiden, The Netherlands.
Ralph C A RippeResearch Methods and Statistics, Institute of Education and Child Studies, Leiden University, Leiden, The Netherlands.
Nico M WulffraatPediatric Immunology and Rheumatology, Wilhelmina Children's Hospital, Utrecht, The Netherlands.
Andrea W M EversHealth, Medical and Neuropsychology unit, Leiden University, Leiden, The Netherlands.ORCID 0000-0002-0090-5091

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesDespite the increasing knowledge about placebo effects and their beneficial impact on treatment outcomes, strategies that explicitly employ these mechanisms remain scarce. To benefit from placebo effects, it is important to gain better understanding in how individuals want to be informed about placebo effects (for example about the underlying mechanisms that steer placebo effects). The main aim of this study was to investigate placebo information strategies in a general population sample by assessing current placebo knowledge, preferences for different placebo explanations (built around well-known mechanisms involved in placebo effects), and attitudes and acceptability towards the use of placebo effects in treatment.

designOnline survey.

settingLeiden, The Netherlands.

participants444 participants (377 completers), aged 16-78 years.

main outcome measuresCurrent placebo knowledge, placebo explanation preferences, and placebo attitudes and acceptability.

resultsParticipants scored high on current placebo knowledge (correct answers: M = 81.15%, SD = 12.75). Comparisons of 8 different placebo explanations revealed that participants preferred explanations based on brain mechanisms and positive expectations more than all other explanations (F(7, 368) = 3.618, p = .001). Furthermore, attitudes and acceptability for placebos in treatment varied for the type of the condition (i.e. more acceptant for psychological complaints) and participants indicated that physicians do not always have to be honest while making use of placebo effects for therapeutic benefit.

conclusionOur results brought forth new evidence in placebo information strategies, and indicated that explanations based on brain mechanisms and positive expectations were most preferred. These results can be insightful to construct placebo information strategies for both clinical context and research practices.

Indexed as

InternetSurveys and QuestionnairesAdolescentAdultAgedFemaleHumansMaleMiddle AgedPlacebo EffectYoung Adult

Identifiers

PMID33705397
PMCPMC7951811

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.